EMA and FDA aligned on marketing authorisations: report

19-08-2019

Sarah Morgan

EMA and FDA aligned on marketing authorisations: report

Alessandro Zappalorto / Shutterstock.com

The US and Europe have reached the same conclusion in more than 90% of marketing authorisation decisions for new medicines, according to a report from the European Medicines Agency (EMA).


EMA, FDA, big pharma, marketing authorisations, regulation, cooperation, European Medicines Agency, Food and Drug Administration

LSIPR